Podcasts about md ceo

GLP-1s have quickly become a cornerstone of obesity and metabolic care — but the real challenge isn't whether they work, it's how the healthcare system uses them. Leaders are grappling with tough questions around hype, access, safety, cost, and long-term sustainability. In this episode, recorded live at the 2025 HLTH conference, Rae Woods moderates a candid conversation with four physician leaders: Angela Fitch, MD: Co-founder and Chief Medical Officer at Knownwell Florencia Halperin, MD: Chief Medical Officer at Form Health Spencer Nadolsky, MD: CEO and Founder of Vineyard Nathan Wood, MD: Director of Culinary Medicine at Yale Drawing from frontline clinical experience and emerging data, the panel explores why medication only approaches fall short, how wraparound care improves outcomes and adherence, and what it will take for GLP 1s to deliver true value for patients, employers, and payers. We're here to help: Ep. 229: Live from HLTH: What Can't GLP-1s Do? Ep. 248: Drugs, surgeries, and shortages: the state of obesity care in 2025 Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Ep. 279: ‘Food as medicine': What it is, why it matters, and how to do it right 5 trends shaping pharma strategy for 2026 (and how to adapt) Innovative solutions to today's obesity care challenges From reactive to proactive care: 4 key takeaways about today's COVID-19 landscape A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, we sit down with Sameer Kanodia, Managing Director and CEO of Lumina Datamatics, to discuss the evolution of content services, the impact of AI on the industry, and his journey as a second-generation entrepreneur.Lumina Datamatics is a leading global provider of content, data, and technology solutions, serving top-tier publishers and international retailers. Sameer breaks down how the company manages massive scale, ensures data security, and leverages automation to stay ahead of the curve. He also shares candid advice for aspiring entrepreneurs on taking calculated risks and why human validation remains crucial in the age of Artificial Intelligence.Topics Discussed:

Today, we are continuing our Standing Out in 2026 series and talking about your visibility. If you caught last week’s episode on mindset habits, you would know we have been diving into the practical actions that will help you stand out in your market this year. Last week was all about what goes on between your ears and the thoughts you are having. This week, we are talking about what you actually do. Specifically, being more active and more visible. Here is the thing: most recruitment business owners know they need to be more visible. They know they should be posting, engaging, and showing up. But they are not doing it. They are too busy, too distracted, or waiting for things to calm down. Spoiler: Things do not calm down. So today we are going to talk about why visibility matters more than ever, what is getting in your way, and how the recruitment businesses that are winning right now are the ones that show up consistently. Key Takeaways: Recruitment Visibility in 2026 61-81% of potential clients check your LinkedIn and website before making contact — an outdated or inactive profile costs your business before you know they exist Visibility compounds over time: content you create today continues generating leads 12-24 months later, building familiarity and trust with future clients The “too busy” trap is a myth — waiting for things to calm down means your competitors become the default choice while you stay invisible Consistency beats perfection: two LinkedIn posts weekly outperform ambitious plans you abandon after a month Personal brands outperform company pages — buyers trust people, not logos, making founder-led content your most powerful marketing asset The Visibility Gap Let's paint a picture for you. Imagine two recruitment business owners. Both are brilliant at what they do. Both have years of experience. Both genuinely care about their clients and candidates. Both have all the knowledge they need to succeed. One of them posts on LinkedIn three or four times a week. Sends a monthly email to their database. Picks up the phone to past clients every few weeks. Shares insights about their market. Comments on other people’s posts. Shows up at industry events. The other one is busy. Really busy. They are on the phone all day with candidates. They are chasing clients. They are doing the work. But their LinkedIn has been quiet for six weeks. Their email list has not heard from them since last quarter. They keep meaning to reach out to that client who placed three candidates with them two years ago, but something always comes up. Now here is the question: when a hiring manager in their sector has a vacancy to fill, which one do you think comes to mind first? It is not even close. And here is what the research tells us. Between 61- 81 % of people will visit a website or social media profile before engaging with a company. That means your potential clients and candidates are checking you out online, whether you realise it or not. They are forming opinions about you based on what they see, or do not see, before you even know they exist. If they land on your LinkedIn and the last post was from three months ago, what does that tell them? If your website feels like it has not been touched in years, what message does that send? We are not saying this to make you feel bad. We are saying it because it is the reality of the market we are all operating in right now. Why We Get Distracted So, if visibility is so important, and we all know it, why do so many recruitment business owners struggle with it? We have been working with recruitment business owners for approaching eighteen years, and we have seen every version of this story. Here are the common patterns we see repeatedly. First, there is the delivery trap. You are so caught up in the day-to-day work of filling roles, managing candidates, and keeping clients happy that marketing always falls to the bottom of the list. And we get it. When you have a client on the phone with an urgent vacancy, that feels more pressing than writing a LinkedIn post. The problem is, urgent always beats important. And marketing is important, even when it does not feel urgent. Second, there is the overwhelm factor. Marketing advice is everywhere, and a lot of it is contradictory. Should you be on TikTok? What about a podcast? Are you supposed to be making videos now? For a small business owner juggling multiple responsibilities, it can feel paralysing. So you do nothing. Third, and this is a big one, there is the “I’ll do it when things calm down” myth. We hate to break it to you, but things do not calm down. There is no magical quiet period where you will suddenly have time to focus on your marketing. If you wait for the perfect moment, you will stay forever. And fourth, there is the shiny object syndrome. You start posting on LinkedIn, then you hear about email sequences, then someone tells you about webinars, then you read about a new platform, and before you know it, you have started five different things and finished none of them. Sound familiar? The Compound Effect of Showing Up Here is what we want you to understand: visibility compounds over time. The content you create today does not just work for you today. A blog post you write this week could still be bringing people to your website 12 or even 24 months from now. A LinkedIn post you put out on Monday might be seen by someone who is not ready to use a recruiter yet, but six months later, when they have a vacancy, your name pops into their head because they have been seeing your content regularly. This is the bit that so many people miss. Marketing is not about instant results. It is about building familiarity and trust over time. People need to see you multiple times before they remember you exist. They need to experience your expertise before they believe in it. We work with a recruitment business owner, Steve. He had been in engineering recruitment for 28 years! Twenty-eight years . But nobody knew who he was. He was working alone in a competitive market, relying solely on one-to-one business development. His LinkedIn sat dormant. His expertise was completely hidden. When he joined our Superfast Circle programme, the transformation did not happen overnight. He admits he stopped and started at first. But eventually, something clicked, and he committed to showing up consistently. Following the process. Using the monthly content. Posting regularly. Within a year, he had won eight new clients. He had generated over £26,000 in fees from LinkedIn alone. His connections were up 35 per cent. But here is the part that really gets us: after nearly three decades of contingency-only work, Steve secured two retained projects worth £36,000 in just two weeks. That did not happen because he learned a secret technique. It happened because he became visible. People could finally see his expertise. Clients were buying into his value before the fee conversation even started. What Being Active Actually Means Now, we want to be clear about something. When we talk about being more active, we are not talking about being everywhere, all the time, doing all of the things! That is a fast track to burnout, and it is not necessary. What we are talking about is a consistent, focused presence in the places that matter for your business. For most recruitment business owners, that starts with LinkedIn. It is still the single most important social platform for B2B. But here is what works: it is not about posting all your company announcements or sharing every vacancy you have. The most effective LinkedIn strategies are founder/MD/CEO-led or consultant-led. Posts that share opinions, lessons learned, and commentary on what is happening in your specific market. Something that makes consistent posting easier is having structured content themes. For example, you might do a weekly market update on Mondays. A candidate tip on Wednesdays. A client challenge you helped solve on Fridays. When you have themes, you are not staring at a blank screen, wondering what to say. You know what Monday’s post is about before Monday arrives. And here is something many people overlook: commenting on others’ posts is just as powerful as creating your own. If your target clients are posting on LinkedIn, and they probably are, then showing up in their comments with thoughtful insights is a high-impact way to get on their radar. IMPORTANT: The goal is not to sell in comments. It is to demonstrate your expertise and build familiarity over time. The keyword in all of this is consistency. You do not need to be perfect. You do not need polished videos and professional graphics. You need to show up regularly enough that people start to recognise your name and associate you with your specialist area. Personal Brand vs Company Brand While we are on this topic, let us touch on something our research made very clear: personal brands matter more than company pages. Buyers trust people more than logos. They respond to content where real human beings share their experiences, their opinions, their expertise. Your company page has its place, but it should not be your primary focus. If you are the founder or MD of a recruitment business, your profile should be the main hub for your content. The company page can amplify and support, but the human connection happens through your personal presence. And if you have consultants on your team, encourage them to build their own presence in their niche. One of the most powerful positioning moves we see is when someone becomes known as the go-to person for a specific thing. The person everyone thinks of for data roles in Manchester. The recruiter who really understands the legal sector. The one who knows the fintech market inside out. You do not need a big team to do this. You need two or three people who are willing to post consistently, share their opinions, and engage in conversations with potential clients. The Cost of Invisibility We want to spend a moment on what happens when you don't do this. Because sometimes we need to feel the cost of inaction to motivate ourselves to act. When you are not visible, you are relying almost entirely on reactive business development. You are waiting for the phone to ring. You depend on existing clients coming back and on referrals happening by chance. And that works, until it does not We have seen this pattern so many times. A recruitment business is ticking along nicely, busy with current clients, not really doing much marketing because there is no immediate need. Then something changes. A key client’s business slows down. A competitor wins away some business. The market shifts. And suddenly, that recruitment business owner realises they have no pipeline. No warm leads. No prospects who know who they are. Now they have to start building visibility from scratch, at exactly the moment when they are under pressure and stressed. That is a horrible position to be in. The feast-and-famine cycle that plagues so many recruitment businesses is almost always a visibility problem. When you are busy, you stop marketing. When work dries up, you panic and start again. Then it takes months to rebuild momentum. It is exhausting and completely avoidable. The Competitors Who Are Showing Up Here is another uncomfortable truth: while you are too busy to post, your competitors are not. The recruiters who are consistently visible in your market are becoming the default choice. They are the ones who come to mind when someone has a hiring need. They are building relationships with your potential clients through their content, even if they have never spoken to them directly. We had a client, Mark, who specialises in technical sales recruitment. He was struggling with his pipeline, feeling invisible in a crowded market. He decided to focus on what he knew best and created a three-part blog series that drew on his experience in engineering and sales. He was shocked at the response. Out of a couple of hundred people, he had around 25% respond with comments and feedback. People he had not heard from in ages were reaching out, saying, “Great article, I loved it.” Some wrote detailed paragraphs about how useful they found it. But here is the bit that matters that content started generating real business opportunities. Mark got a contract signed, submitted candidates, and had interviews ongoing. Within two months, he had eight to ten active roles and the potential to cover a full year’s revenue. That is the power of showing up and sharing what you know. The Permission to Start Small If you are listening to this and feeling a bit overwhelmed, we want to permit you to start small. You do not need to become a content machine overnight. You do not need to post twice a day or create videos every week. What you need is a minimum viable visibility plan. Something you can stick to. Maybe that is two LinkedIn posts a week to start with. Perhaps it is one email to your database every fortnight. Maybe it is setting aside 15 minutes a day to comment on posts from people in your network. The specific activities matter less than the consistency. Something small that you do every week will always beat something ambitious that you do for a month and then abandon. Finally The recruitment businesses that will stand out in 2026 are not necessarily the ones with the biggest budgets or the fanciest websites. They are the ones that show up consistently. The ones who become familiar. The ones who build trust over time by sharing what they know and demonstrating their expertise. Your competitors who are posting while you are too busy? They are building relationships with your future clients right now. The content you create today keeps working for you for months, sometimes years. That is the compound effect in action. And the best part? You do not need to do everything. You need to do something consistently. So here is our challenge for you this week. Whatever your minimum viable visibility plan looks like, start it. Not next Monday. Not when things calm down. This week. Because the only way to become front of mind is to be present, and the only way to be present is to show up. Thanks Denise How We Can Help You This Year If you know you need to be more visible but are struggling to make it happen on your own, that is exactly what we help with in Superfast Circle. Our members get done-for-you content they can personalise and use, so they are not staring at a blank screen, wondering what to write. They get the systems and frameworks that make showing up straightforward rather than overwhelming. And they get the support and accountability of a community that understands exactly what it is like to run a small recruitment business. If you would like to find out more about how we can help you build your visibility and stand out in your market, book a call with us at superfastrecruitment.co.uk/call. We would love to chat about where you are right now and where you want to be. The post Standing Out in 2026: The Visibility Gap – Why Some Recruiters Win Clients (And Others Remain Invisible) appeared first on Superfast Recruitment.

Send us a textDr. Andrew Holman, MD is Co-Founder & Chief Executive Officer of Inmedix ( https://inmedix.com/ ), a medical diagnostics company pioneering the field of stress biology through its FDA-cleared CloudHRV® platform. Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.Dr. Holman is the founding rheumatologist at Pacific Rheumatology Associates Inc PS, Director of Research at Pacific Rheumatology Research Inc., a former President of the Northwest Rheumatism Society (2005) and a Clinical Associate Professor of Medicine at the University of Washington.Dr. Holman has 25 year clinical (and 19 year rheumatology) research career experience with 16 lead author published papers, and 25 lead author published abstracts.  For Inmedix, he has designed, completed and published 15 clinical studies, including FDA negotiations, involving nearly 1500 patients.Dr. Holman's research highlights include, but are not limited to, studying the use of dopamine agonists as a treatment of fibromyalgia, exploring the impact of hypermobility syndromes, evaluating innovative autonomic nervous system (ANS) analysis with 5-min heart rate variability (HRV) in patients with rheumatoid arthritis and other autoimmune diseases, and broadening understanding of pain in patients with PC3 (positional cervical cord compression) using dynamic flexion-extension, cervical magnetic resonance imaging (dMRI). Dr. Holman has his Doctor of Medicine (M.D.), Medicine from University of Missouri-Columbia and did his Rheumatology Fellowship at the University of Washington - School of Medicine.#AndrewHolman #Inmedix #CloudHRV #ClinicalDiagnostics #ImmunoAutonomics #AutoimmuneDiseases #StressBiology #Rheumatology #Fibromyalgia #RheumatoidArthritis #HeartRateVariability #HRV #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

In this episode of The Brand Called You, Sundararaman Ramamurthy, MD & CEO of BSE, reflects on four decades in capital markets, contrasting global banks with domestic institutions, decoding BSE's resurgence, and sharing lessons on leadership, regulation, innovation, and purpose-driven growth.00:48- About Sundararaman RamamurthySundararaman is the MD & CEO of BSE.

00:00-30:00: Optimal MD CEO Shawn Fry chats about the company coming to fruition and the benefits, why it offers so much, healthcare issues in the U.S., his love for Phili sports yet being a Chiefs fan, being suitemates with Andre Reed, why he feels so good at age 61, why medical people are taking advantage of us daily, why Optimal is simpler than you think and more. Visit OptimalMD.com and use code MLSP to get started now. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

A powerful conversation with Deepak Khetrapal, where he reflects on his 51-year leadership journey—from bold early decisions to fostering safety, humility, and human connection in times of crisis. His story reveals how curiosity, courage, and compassion shape extraordinary leaders.00:31- About Deepak KhetrapalDeepak is the former Managing Director and Chief Executive Officer of Orient Cement Ltd.He's also the former VC and MD of Orient Electric Ltd.

00:00-30:00: Optimal MD CEO Shawn Fry chats about the company coming to fruition and the benefits, why it offers so much, healthcare issues in the U.S., his love for Phili sports yet being a Chiefs fan, being suitemates with Andre Reed, why he feels so good at age 61, why medical people are taking advantage of us daily, why Optimal is simpler than you think and more. Visit OptimalMD.com and use code MLSP to get started now. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textDr. Marc Hedrick, MD is President and CEO of Plus Therapeutics, Inc. ( https://plustherapeutics.com/ ), a U.S. clinical-stage pharmaceutical company, focused on developing innovative, targeted radiotherapeutics for adults and children with difficult-to-treat cancers of the central nervous system. The company's lead programs focus on leptomeningeal metastases (LM) and recurrent glioblastoma (GBM), leveraging image-guided local beta radiation and targeted drug delivery to improve outcomes.Additionally, Plus' subsidiary CNSide Diagnostics develops proprietary lab tests such as CNSide®, designed to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The CNSide® CSF Assay Platform enables quantitative analysis and molecular characterization of tumor cells and circulating tumor DNA in the cerebrospinal fluid that inform and improve the management of patients with leptomeningeal metastases.Previously, Dr. Hedrick served in a number of executive leadership roles including President, CEO, and Director at Cytori Therapeutics, Inc., and President and CEO of StemSource, Inc.  Dr. Hedrick is a trained general, vascular, and plastic surgeon and former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA).  Dr. Hedrick also served as Co-Director of the Laboratory of Regenerative Bioengineering and Repair at UCLA.Dr. Hedrick obtained his MD from the University of Texas Southwestern Medical School, Dallas and a MBA from The Anderson School at UCLA in 2005.#MarcHedrick #PlusTherapeutics #Radiotherapeutics #Cancer #CentralNervousSystem #Glioblastoma #LeptomeningealMetastases #Rhenium #ConvectionEnhancedDelivery #Oncology #Theranostic #NanoliposomeTechnology #Radioembolization #AlginateMicrospheres#BMEDAChelation#CNSide #REYOBIQ #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this inspiring episode of TBCY, host Sandeep Tyagi sits down with Ashish Kumar Chauhan, the Managing Director and CEO of the National Stock Exchange of India (NSE), known as the father of modern financial derivatives in India. Ashish shares his incredible journey from a small village in Gujarat to building India's most advanced stock exchange and pioneering technological revolutions in the financial ecosystem. Discover behind-the-scenes stories from the founding days of NSE, challenges faced, and his philosophy of "Sthit Pragya"—maintaining equilibrium in the face of ambition and adversity.We dive deep into the evolution of India's capital markets, retail investor participation, the transformative power of technology like AI in finance, and valuable career advice for young professionals. Ashish also opens up about his personal life, values, and passions beyond work, including his love for cricket and social causes.Whether you're interested in finance, technology, or personal growth, this episode is packed with wisdom, anecdotes, and reflections from one of India's most influential financial leaders.

In this illuminating episode of the Self-Care Goddess Podcast, I sit down with Dr. Larry Weiss, MD—CEO and founder of Symbiome Skincare and a pioneer in microbiome science—to explore how our mighty microbiome shapes everything from our skin health to aging, immunity, and overall resilience.Dr. Weiss takes us on a fascinating journey from the Amazon rainforest to the modern skincare lab, revealing how reconnecting with the microbial world can restore our health, balance, and beauty.✨ Here's what you'll learn in this empowering conversation:✅ What your microbiome really is—and why it's essential to your health and longevity✅ How modern lifestyles have depleted our natural resilience and disrupted the skin microbiome✅ The link between gut health, skin health, and inflammation✅ How fermented foods and probiotic skincare can help rebuild your inner and outer ecosystem✅ Why your skin is a mirror of your overall wellbeing✅ The truth about hand sanitizers, hygiene, and microbiome balance✅ How Symbiome's fermented skincare works with nature—not against it—to restore your skin's natural vitality✅ Dr. Weiss's top 3 self-care rituals for daily health, joy, and connection

Send us a textDr. Adam Rogers, MD is Chief Executive Officer of NervGen Pharma Corp. ( https://nervgen.com/ ) a clinical-stage biotech company dedicated to developing innovative treatments to enable nervous system repair in the settings of traumatic injury and disease. NervGen's lead drug candidate, NVG-291, is being evaluated in mid stage clinical trials in an initial target indication, spinal cord injury. NervGen has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury.Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous, and previously co-founded and served as CEO of Hemera Biosciences, a clinical stage gene therapy biotech company targeting dry age-related macular degeneration where he oversaw all aspects of the company until the Hemera assets were acquired in December 2020 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.From 2001 to 2020 Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center of Tufts Medical Center (Boston, MA). Dr. Rogers has published 29 articles in peer reviewed journals and co-authored two textbooks and numerous chapters in major ophthalmic textbooks. Since 2007 he has served on the board of One Family Inc., an organization whose mission is to end homelessness in Massachusetts. He is a member of the Emory University Board of Trustees. Dr. Rogers has a MD from Emory College and Emory School of Medicine.#SpinalCordInjury #SCI #IschemicStroke #AmyotrophicLateralSclerosis #ALS #NervGen #Rehabilitation #RegenerativeMedicine #RegenerativeBiology #ChondroitinSulfateProteoglycans #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Send us a textDr. Jacob Lalezari, MD is the Chief Executive Officer of CytoDyn ( https://www.cytodyn.com/ ), a biopharma company committed to enhancing the lives of patients through target specific medicine and a next generation of monoclonal antibody therapeutics. CytoDyn's team is focused on developing leronlimab, a monoclonal antibody CCR5 receptor antagonist, to be used as a platform drug for a variety of indications. Dr. Lalezari brings over 34 years of industry experience to CytoDyn, including nearly 20 years of experience with leronlimab, also known as PRO 140, and he previously served as interim CEO and Chief Medical Officer and has been a member of the Company's scientific advisory board for the past several years.  Dr. Lalezari has previously served as the CEO and Medical Director of Quest Clinical Research and served as the Chief Medical Officer of Virion Therapeutics. Dr. Lalezari has served as Principal Investigator for Phase I, II, and III clinical studies of new therapies for such viral diseases as HIV/AIDS, CMV, HPV, HSV, Hepatitis B and C, influenza, RSV, and COVID-19, including clinical trials conducted by the Company. His work has been published extensively and he is a well-regarded international speaker and patient advocate. Dr. Lalezari received his M.D. from the University of Pennsylvania, his M.A. from the University of Virginia, and his B.A. from the University of Rochester. He also holds a board certification from the American Board of Internal Medicine.#JacobLalezari #Cytodyn #MonoclonalAntibody #Leronlimab #CCR5Receptor #CCR5Antagonist #ChemokineReceptor5 #HIV #AutoimmuneDisorders #HIVCoReceptor #Macrophages #DendriticCells #TripleNegativeBreastCancer #TLymphocytes #MetastaticColorectalCancer #PD1 #ProgrammedCellDeathProtein1 #Oncology #Immunooncology #Cancer #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textDr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche's headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.#MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases  #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textDr. Samir Khleif, MD is CEO of Georgiamune ( https://www.georgiamune.com/team ), a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.  Dr. Khleif is a pioneer in the field of immunotherapy. He is a medical oncologist, immunologist, innovator, and entrepreneur, as well as a transformational executive in health care and biomedical research.Prior to becoming CEO of Georgiamune, Dr. Khleif served in different academic and leadership positions. He was a National Cancer Institute (NCI)/National Institutes of Health (NIH) scientist and Chief of the NCI Cancer Vaccine Section, where he led the development of pioneering immune-oncology and cancer vaccines into clinical trials. As a national and international academic leader, and detailed by the US government, he served as the founding director and CEO of the King Hussein Cancer Center ( https://www.khcc.jo/en ) in Amman, Jordan, where he led the development of the largest cancer center in the MENA region. He also served as the director of the Georgia Cancer Center, the state cancer center, at Augusta University. He is currently a biomedical scholar and holds a professorship at Georgetown University Medical School.Dr. Khleif also served as a Special Assistant to the Commissioner of the FDA, leading the FDA's Critical Path Initiative for Oncology. He is a member of the board of directors of Ayala Pharmaceuticals and Emerald Biopharmaceutics, and served as a member of the scientific advisory board of more than 20 biotechnology and pharmaceutical companies.Dr. Khleif is an international KOL in immunology and immunotherapy. He has served on many national committees, including the Scientific Advisory Board of the Biden Cancer Initiative, as chair of the Immunotherapy Committee for NRG, and as a member of the NCI Cooperative Group. He currently serves as an advisor for the Parker Institute for Cancer Immunotherapy. Dr. Khleif is an editor of three books, the author of hundreds of peer-reviewed scientific research articles, and a prolific inventor with more than 150 patents issued or pending in the field of immunology and immunotherapy.Dr. Khleif received his medical degree at the University of Jordan, Amman Jordan. He completed his residency in Internal Medicine at the Medical College of Ohio and his fellowship in Medical Oncology at the National Cancer Institute (NCI) in Bethesda, Maryland.#SamirKhleif #Georgiamune #Immunotherapy #KingHusseinCancerCenter #CriticalPathInitiative #FDA #Tregs #RegulatoryTCells #Cancer #Oncology #CheckpointInhibitors #ImmuneEscapeMechanisms #DualFunctioningAntibody #Autoimmune #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

In this episode, Oluwakayode and The Guru analyzed news stories from different newspaper front pages.

In our International Women's Day Series, we interviewed powerful women who took us through their journeys, challenges, and triumphs—celebrating resilience, leadership, and impact.

Send us a textDr. Hernan A. Bazan MD, FACS, CEO & Co-Founder of South Rampart Pharma, Inc. ( https://southrampartpharma.com/about-us/hernan-bazan/ ), a clinical stage biopharma company developing safer, non-opioid therapies for acute and chronic pain, where he spearheads the company's scientific, clinical and technology development efforts, as well as it's fundraising. As an academic vascular surgeon, Dr. Bazan is the John Ochsner Endowed Professor of Surgery in Innovation ( https://www.ochsner.org/doctors/hernan-bazan ). His clinical interests include treating carotid artery disease and acute stroke, using minimally invasive approaches to aortic aneurysms and peripheral arterial disease, and managing acute post-operative pain. Over the years, Dr. Bazan has realized the significant clinical and societal need for safer and non-addictive pain relief in ambulatory and post-operative settings. From these critical unmet needs, South Rampart Pharma, Inc. was founded in 2016 to develop safer, non-opioid therapies for acute and chronic pain.Dr. Bazan authored the first manuscript describing the library of analgesic compounds' synthesis, lack of hepatoxicity analgesic characterization, and antipyretic properties, published in September 2020 in the European Journal of Medicinal Chemistry and a current paper under advanced review (open access) in Nature Communications.Dr. Bazan is the PI or Co-I on two NIH/NINDS STTR (small business commercialization) grants to develop a novel non-narcotic and non-toxic analgesic to safely treat acute, chronic, and neuropathic pain. He is the co-inventor of 7 issued or pending patents and has authored over 50 publications. He and his team have completed Phase 1 clinical trials, paving the way for Phase 2 RCTs in acute and neuropathic pain. He was bestowed the 2024 NIH HEAL Director's Trailblazer Award for this work.Dr. Bazan received a B.S. in Molecular Biology (Vanderbilt University). He spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. He earned an M.D. (Georgetown University), followed by a General Surgery Residency (Mt. Sinai Hospital, New York) and a Vascular Surgery Fellowship (Yale University).#Pain #Opioids #NSAIDS #Acetaminophen #Analgesia #Nociception #PostOperative #HernanBazan #NicolasBazan #SouthRampartPharma #Ochsner #Fentanyl #Aspirin #Ibuprofen   #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

In The Space Business is... – the podcast series of The Space Business is Everywhere campaign, underwritten by ST Engineering iDirect – we take a look at the way the commercial space industry has spread itself to parts of the world where space and satellites were once only read about or dreamed of. Each episode will on a specific location and features an innovator who is shaping - and reshaping - the industry. In the second episode, we hear from Jane Egerton-Idehen, CEO of Nigerian Communications Satellite Limited (NIGCOMSAT). Jane Egerton-Idehen is a seasoned professional Tech Executive, Author and Angel Investor. She is a dynamic executive with over 20 years in leadership roles across telecommunications, technology and satellite industries. She is currently the MD/CEO of Nigerian Communications Satellite Limited (NIGCOMSAT), leading the nation's foremost agency in charge of managing the operations and services of the communications satellite owned by Nigeria. She has previously held high-level positions at Meta, Avan Communications, Ericsson and Nokia Siemens Network. With proven expertise in driving strategic growth, fostering C-level relationships and implementing revenue-generating sales strategies across multi-national markets, Egerton-Idehen is recognized among Nigeria's top corporate leaders, with a focus on emerging markets, strategic consulting and innovative technology solutions. She was the Head of Sales, Middle East and Africa, Meta and Country Manager & Regional Sales Director for the West African branch of Avan Communications Group PLC. She cumulatively spent 13 years in Sales and Management in the telecommunication infrastructure giant — Ericsson. She also worked as a Cluster lead for Nokia Siemens Network in West Africa. Egerton-Idehen was born and raised in Lagos, Nigeria. She has a degree in Electronics Engineering in 2001 from the University of Nigeria, Nusska; a Master's Degree from Warwick Business School, US; and an executive education from Yale School of Management, US. She has worked in the telecommunications industry in Africa for more than 17 years. Being one of the few females heading key business areas in the tech industry has exposed her to numerous professional and personal challenges peculiar to women. Spurred by discussions with fellow female executives round the globe, she organized a forum at Ericsson in which emerging and experienced female leaders could support each other in developing their careers. The overwhelming success of the forum led her to found Women and Career to reach women beyond her organization and to support girls seeking careers after school. In March 2020, she published a book, Be Fearless: Give Yourself Permission To Be You. She drew from her more than 15 years of experience as a telecommunication executive in Africa to help women build lasting careers, especially in the male-dominated STEM industries. Egerton-Idehen has continued to be actively involved in speaking to girls and women about STEM careers. She has spoken at TEDx programs, the African Science Academy, Asheshi University in Ghana, and CFA's Startups Hangout and many more. She was awarded the Most Outstanding Female CEO of 2024 by the 5th Business and Excellence Awards. She is also the recipient of the Womenovate INWED2024 Women Impact Leader Awards. Egerton-Idehen volunteers for the ACE Foundation's Young Career and Graduate Mentorship Programme, and she is an aspiring fellow of the Aspen Global Leadership Institute. A home girl at heart, she actively gives back to the Ajegunle community of Lagos through the Sozo Network's #BeforeITurn18 program, which prepares underserved teenage girls for life, career and leadership.

In this episode Steven Hanks, MD, CEO of St. Joseph's Health, shares how he balances his executive responsibilities with regular clinical shifts in the emergency department. Discover how his hands-on leadership fosters morale, enhances decision-making, and strengthens connections across the organization.

About Dr Adeel Khan, MD - CEO and Founder of Eterna Health Interventional Cell and GeneTherapy Specialist: Dr. Adeel Khan, MD, is a trailblazer in regenerative medicine, transforming how we think about health, longevity, and recovery. As a Canadian Board-Certified Physician, Dr. Khan has pioneered cutting-edge therapies using stem cells and peptides—modalities now making headlines around the globe. Recognized worldwide, Dr. Khan's impact resonates among healthcare professionals, elite athletes, and individuals from diverse walks of life. His groundbreaking treatments have earned him the trust of renowned figures, including celebrities, such as Chris Hemsworth, life coach Tony Robbins, Chris Bumstead (popularly known as “cbum,” a top fitness influencer), and Mohamed Alabbar, the visionary developer behind the iconic Burj Khalifa. Dr. Khan's work is being discussed across major media outlets, with a focus on the potential of stem cell therapies to redefine healthcare. His ability to deliver real results is changing the conversation on what's possible in modern medicine. Dr. Khan's unwavering dedication to understanding cellular physiology and the art of cellular repair has led to collaborations with scientists in Canada, the USA, Mexico, Dubai, Italy, and Japan. These partnerships have helped shape Eterna Health, a revolutionary concept in specialized healthcare offering unparalleled treatment options that stand out in the medical landscape. Connect with Dr. Khan: Website: Eterna Health Instagram: @dr.akhan YouTube: Doctor Adeel Episode Summary: In this episode, Dr. Cassie Smith hosts Dr. Adeel Khan, a Canadian board-certified physician specializing in regenerative medicine, to discuss stem cells. Dr. Khan explains the unique properties of stem cells, particularly mesenchymal stem cells (MSCs), and their potential to treat chronic diseases, aging, and cosmetic issues. The conversation covers the science behind stem cells, their therapeutic applications, and the limitations of conventional medicine. Dr. Khan also addresses ethical concerns, regulatory challenges, and the future of stem cell research, emphasizing the transformative potential of regenerative medicine. Show Highlights: (00:02:35) Frustration with Conventional Medicine (00:04:46) Understanding Stem Cells (00:05:49) The Role of Stem Cells in Healing (00:06:27) Stem Cells and Aging (00:11:34) Clinical Applications of Stem Cells (00:14:54) Common Uses for Stem Cell Treatments (00:16:13) Stem Cells are Transforming Cosmetic Procedures (00:18:36) Stem Cells are the Body's Super Repairman (00:19:00) Smart Stem Cells?? They're Amazing! (00:20:52) Unbelievable Patient Results with Stem Cells (00:24:39) Stem Cells for Healing Autoimmune Conditions (00:29:30) FDA Regulations on Stem Cells (00:39:02) Potential of Stem Cells in Healing (00:46:24) Can Stem Cells Render Transplants Obsolete? (00:52:04) Future of Medicine with Stem Cells Connect with Modern Endocrine: Check out the⁠⁠⁠⁠⁠⁠⁠ ⁠website⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠ Sign up for Modern Endocrine's⁠⁠⁠⁠⁠⁠⁠ ⁠newsletter⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Disclaimer ⁠⁠⁠⁠

In this episode of "The Brand Called You," Shilpa Pophale, Managing Director of Electronica Finance Limited, shares her groundbreaking insights into MSME financing, rural entrepreneurship, and financial inclusion. With over 30 years of experience, Pophale has transformed her organization from a ₹495 million enterprise to a ₹37 billion powerhouse, pioneering innovative lending strategies that support small businesses across India. 00:34- About Shilpa Pophale Shilpa is the Managing Director and Chief Executive Officer of Electronica Finance Limited.  She was conferred with the Woman Entrepreneur of the Year by the World Women Leadership Congress in 2014. She is also a YPO member. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

So, it turns out that how we frame failure is far more important than how we manage success, in determining our motivation and our ability to sustain healthful and positive ...

Host Tom Foley invites Dr. John Blair the CEO of MedAllies for the first of a 2 part series on TEFCA and interoperability. MedAllies has recently been designated a QHIN by the ONC Recognized Coordinating Entity (RCE), The Sequoia Project. What does that mean and what value does it bring to healthcare providers? To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Gurus, what an honor it is to have the Honorable Mark Dybul, MD CEO of Renovaro Biosciences, on this episode. Dr. Dybul has had such an amazing career working at some of the highest levels of government agencies. He has led teams solving arguably the biggest health challenges ranging from HIV, Tuberculosis and Malaria. We have such a wide-ranging and informative discussion covering how as a CEO you can be more efficient managing deliverables in parallel and why Africa will become the largest global medical market. Get out your notepads as Dr. Dybul brings amazing information in this episode!      

Clare Bertucio is the chief executive officer of Medicine Mama's Apothecary, a company offering organic skincare and personal care products. BOLDLY PURE VULVA CARE . . **This is not medical advice, just medical education. Please ask your doctor medical questions as they pertain to your specific situation. Educational purposes only. #SkyWomensHealthPodcast #EmpowerHerHealth #PureVulvaCare #SelfCareJourney #BOLDLYPURE #WomankindWellness #HolisticHealthTalks #OrganicSkincare #PersonalCareProducts #InTouchWithYourBody #MedicalEducation #AskYourDoctor #EducationalPurposesOnly Dr. Carolyn Moyers, DO is a board certified OBGYN and Neuromusculoskeletal Medicine physician, and founder of Sky Women's Health, a boutique practice in Fort Worth, Texas. Welcome to the Sky Women community where we are all stronger together. COME SAY HI!!! Instagram: https://www.instagram.com/skywomenshealth https://www.instagram.com/drcarolynmoyers Facebook: https://www.facebook.com/skywomenshealth Email: hello@skywomenshealth.com Sky Women's Health: Https://www.skywomenshealth.com 1125 S Henderson St, Fort Worth, TX 76104 To become a patient: email hello@skywomenshealth.com or call 817-915-9803. Listen to the SKY WOMEN PODCAST here: ITUNES: https://podcasts.apple.com/us/podcast/sky-women/id1541657642  SPOTIFY: https://open.spotify.com/show/79VnnWYtGJwlB7NrjBck7o?si=qWXpiBtPSS6OVOt0ki8EiQ --- Send in a voice message: https://podcasters.spotify.com/pod/show/skywomen/message

Host Justin Barnes aka @theHITAdvisor, talks to David Craig MD the CEO of Spruce Health, a cloud-based healthcare communications company that powers modern, innovative medical care, dedicated to enabling medicine that occurs outside of face-to-face interactions and office visits. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Host David Harlow speaks with A. John Blair III, MD, CEO of MedAllies, one of the first cohort of QHINs recently approved under TEFCA. John had been working on health data issues for decades as a practicing physician, as an IPA leader and as a health data exchange executive, and this represents a leap forward in addressing data access, interoperability and usability. John shares some insights on where we are and where we're going on this continuing journey. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Interview with Alex Underwood, MD/CEO of Empire Energy Group Ltd.Our previous interview: https://www.cruxinvestor.com/posts/empire-energy-asxeeg-technical-analysis-due-diligence-4162Recording date: 26th January 2024Empire Energy controls huge shale gas resources in Australia's Northern Territory, estimated at over 40 trillion cubic feet by independent assessors. With domestic east coast markets facing looming supply shortfalls amid rising global demand, Empire has a clear strategic production roadmap to monetize these world-scale gas assets.Initially focussed on oil and gas production in the US, Empire pivoted towards acquiring and proving up acreage in the vast onshore Beetaloo Basin after capitalizing on the US shale boom's early stages. Australia's Beetaloo region shares similar shale geology and Empire moved swiftly to build a dominant position. Few companies boast more prime shale acres.Having confirmed world-class volumes of gas in place via drilling vertical and horizontal test wells, Empire is fast-tracking low cost pilot schemes. An initial 3 well development campaign with 60 stage hydraulic fracturing aims to flow test production potential. Early success would derisk substantial follow-on development, likely attracting industry interest.Empire has accelerated pilot production plans by acquiring a second-hand gas facility for a bargain $3 million. Refurbishing this will expedite on-site infrastructure assembly. Along with advanced talks on securing gas sales agreements, first cash flow now looks possible inside 12 months.Beyond pilot schemes, Empire has a multi-stage production growth plan. Phase one fills spare capacity in an existing pipeline traversing Empire's permits. Rapidly expanding output from 25 million cubic feet per day to feed Darwin's energy shortfall would generate over $100 million annual revenue. Subsequent phases look to ramp up production, ultimately targeting 1 billion cubic feet daily for southern LNG exports. Attractive economics expected from initial wells provides cashflow to fund each organic development stage.From an early entry point, Empire Energy offers leveraged exposure to realization of the Beetaloo Basin's full potential. Key de-risking milestones are approaching fast. Cash flow and resource appraisal progress could spotlight Empire's world-scale gas resource. Its disciplined step-by-step commercialization strategy aims to capitalize on strengthening gas market conditions. Targeting first production within 12 months provides investors a near term catalyst.—View Empire Energy Group's company profile: https://www.cruxinvestor.com/companies/empire-energy-groupSign up for Crux Investor: https://cruxinvestor.com

The Pharmacy Podcast Network is proud to bring you healthcare and business information from our trusted source and monthly guest, Dr. Gail Lebovic.  We're covering important topics and bringing health and wellness to your community by bridging the gap between pharmacies, physicians and patients.   This monthly podcast is sponsored by Silicon Valley Innovations, makers of NasoClenz. The time of year is upon us when blistering heat gives way to colder weather.  With the change of seasons come a multitude of challenges for the nose, sinuses and lungs.  Allergens, dust, air pollution, particulate matter in the air, changes in barometric pressure and respiratory viruses can all wreak havoc on our respiratory systems leading to nasal congestion, post nasal drainage, coughing, wheezing, fatigue and eventually sinusitis and even pulmonary infections such as bronchitis.      Join our host Todd Eury as we welcome our guests live from the floor at the American Academy of Otolaryngology Head and Neck Surgery Annual Meeting in Nashville, TN    Keith Matheny, MD - Medical Entrepreneur & Otolaryngologist Gail Lebovic, MD - CEO & Founder of Silicon Valley Innovations and creator of NasoClenz

Join us for a captivating episode of the Becker's Healthcare podcast featuring Dr. Hilton M. Hudson, a board-certified cardiothoracic surgeon and Chief of Cardiothoracic Surgery at Franciscan's Michigan City and Olympia Fields health systems, as well as the CEO of HPC International Inc. Dr. Hudson shares his unique insights on the healthcare industry, discussing the critical issue of personnel shortages and labor tension while delving into the origins and mission of HPC International. He also reflects on the journey towards health equity and the evolving dynamics of leadership in healthcare. Don't miss this engaging conversation with a seasoned healthcare leader who has made a significant impact on the industry.

On this special Fireside Chat, HFS CEO and Chief Analyst Phil Fersht is in conversation with Mohit Joshi, Managing Director and CEO Designate at Tech Mahindra about his personal and digital business journey. With over two decades of experience in enterprise technology software and consulting, Mohit has worked with the largest corporations in the world in driving digital transformation and building thriving businesses. He has been a Non-Executive Director at Aviva Plc since 2020 and is a member of its risk and governance and nomination committees. Prior to joining Tech Mahindra, Mohit was President of Infosys Limited. He started his career in banking with ABN AMRO and ANZ. Phil and Mohit cover a range of topics, including: Before we get into the industry talk, can you share a bit about your background? Also, have you always wanted to lead a huge global technology business? Who's been your main influence during your inexorable career rise? So, this brings us to Tech Mahindra – taking over a heritage business like this during a major time of change in our industry is a huge challenge – what will you bring to the table? You've been one of the major faces of financial services over the past decade-plus and now you've joined a company that leads in the telecom sector, so how do you plan to grow the industry focus in Tech M? Can you compete in BFS with the leaders, or will this take time? Are you enthusiastic or scared about AI? Why? How do you see software and services being impacted by GenAI? Can the current crop of leading firms change their products and delivery models to stay relevant? Do you believe white-collar jobs are under threat with Gen-AI? Do you believe our education system is going to be rocked with so many kids using it for their coursework Finally, if you had one wish for the IT services industry, what would that be?

This episode featured Princess Funlayo Bakare-Okeowo, MD/CEO of FAE Ltd, the largest envelope manaufcturing company in Nigeria. Princess Funlayo has over 40 years experience in the manufacturing sector. She was interviewed by Chidiebere Nnorom, Founder/CEO, Paperbags by Ebees, an eco-friendly packaging company. We are certain that you will be inspired by their journeys in Entrepreneurship in the manufacturing space. Don't forget to share your feedback, comments and experience with us in the comment section.

As we journey towards net-zero emissions by 2050, energy crises around the world are on the rise, pointing to the inevitable need for hydrocarbons as we transition. Africa is rich in hydrocarbons, so how can the continent secure global energy demand with its resources? To find out, Business Day TV spoke to Adeg-bite Falade, MD & CEO of Aradel Holdings.

Another fruitful day of news to analyse, with the revolving door at Fortescue (FMG) again being a talking point as two further senior figures leave the company. We then delve into the Bald Hill debacle, which appears to have an imminent end to it, with a mysterious bidder for the prized asset lurking. A quick mention for Sayona (SYA) and Morella (1MC), who share an MD/CEO, then onto a deep dive into AuTECO's $50m acquisition of the Green Bay Copper-Gold project in Eastern Canada. We round off the week with more news out of Canada as uranium developer NexGen (NXG) announces funding via a US$110m convertible note. All Money of Mine episodes are for informational purposes only and may contain forward-looking statements that may not eventuate. The co-hosts are not financial advisers and any views expressed are their opinion only. Please do your own research before making any investment decision or alternatively seek advice from a registered financial professional. Thank you to our Podcast Partners:Terra Capital – Specialist Investment manager in the natural resources sectorAnytime Exploration Services – Exploration workers, equipment, core cutting/storage + much moreJP Search – Recruitment specialists for the financial worldK-Drill – Safe, reliable, and productive surface RC drillingTopdrill – Drilling into the future Join our exclusive Facebook Group for the Money Miners and request access to the Hooteroo chat group. Subscribe to our weekly newsletter HOOTEROO HERALD Follow Money of Mine on YouTubeFollow Money of Mine on TwitterFollow Money of Mine on LinkedInFollow Money of Mine on Instagram Chapters:(0:00) Preview(0:41) Intro(3:07) The Revolving Door at Fortescue Continues(12:55) Alita's Bald Hill to be Changing Hands Imminently!(20:54) Sayona & Morella's Busy CEO(23:36) AuTECO Scoop up Canadian Copper Asset(37:32) NexGen Secure Convertible Debt Funding

Friends, In my upcoming book, Beyond The Walls, I spend an entire chapter discussing how platforms have revolutionized other industries and how they're about to do the same in healthcare.  ...

A need for actionable insights has held back healthcare, but better health outcomes can come with innovative analytics and incentives. In this episode, Jean Drouin, Founder and CEO of Clarify Health, talks about making a system-level impact in healthcare by using data insights to smooth everyone's journey in the care setting. He explains how Clarify Health provides clinicians with the tools they need to keep patient satisfaction high and avoid burnout, coming full circle with the goals he set himself from the very beginning of his career. Tune in to learn how information can lead to a better healthcare industry and empowered patients! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Host Dr. Nick van Terheyden aka Dr. Nick, discusses Integrated Virtual Care with Lyle Berkowitz, MD, CEO of Keycare. Their discussion includes Lyle's long career in medicine and the intersection of business and technology, being CMIO and clinician at Northwestern Medicine in Chicago, helped build early innovation centers for healthcare, and more. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On Episode 9 , I spoke with Shiv Rao. Dr. Rao is the founder and CEO of Abridge, which uses ambient AI to summarize conversations into clinical documentation. He is also a practicing cardiologist, and previously led the provider-facing investment portfolio for UPMC. “What did the doctor say?" is inevitably the first question we ask a loved one who has just been to see a clinician. But how often do we get a clear answer ? How many of our loved ones are actually knowledgeable enough to grasp the details of their condition/diagnosis/care plan? Research out of Dartmouth suggests that people forget up to 80% of what they've heard from their healthcare professional. That's what makes Abridge so important, and is likely the reason that over 300,000 people are using the free version of the Abridge app (which you can download here on the app store) to help make sense of medical conversations and share information from clinical consultations with loved ones.As Dr. Rao pointed out in our conversation, there is a public health emergency occurring in the United States - we do not have the supply of clinicians necessary to meet the demands for care delivery. Compounding a lack of clinicians is an uptick in burnout. The AMA currently estimates that physician burnout is at 63%, and an article in the Journal of Internal Medicine that said clinicians would need 27 hours per day to do all the work that's required of them. Shiv started Abridge to reduce the documentation burden on physicians, and to provide patients with a digestible, “translated” version of their clinical encounter that they can share with family members.  The benefits are also significant for clinicians. Over 80% of the clerical work that used to be involved in documenting is now getting automated by Abridge - this solution is currently saving clinicians on the platform an average of 2 hours a day! Ultimately, as we discussed, a clinical note has three stakeholders:Other clinicians on the care team - they need to understand Dr. Rao's medical differential, and how he was thinking about the diagnosis/care plan.Health plans - Dr. Rao needs to build his note in such a way that the diagnosis and follow-up recommendations can be properly coded and billed.Patients and their family members, who may need to take action based on Dr. Rao's findings, which they thus need to understand.A single note cannot be all of those things at once. Abridge solves this problem by summarizing and structuring the information to create different artifacts for all three sets of customers.Abridge has raised $27 million to date from investors like Union Square Ventures, Bessemer Venture Partners, and Wittington Ventures. For more information,  you can check out their website: https://www.abridge.comPlease make sure to check out the Society for HealthCare Innovation's (SHCI) website for more content. 

April 27: Today on the Conference channel, it's an Interview in Action live from ViVe 2023 with Ali Rahimi, MD, CEO & Founder of ALYKA Health Technologies. What inspired Ali to create ALYKA Health, and how did he recognize the gaps in healthcare that his platform addresses? What specific data elements are included, and how is this information used to target education and improve engagement? What is the goal of the health resilience index, and how does it help improve health outcomes? How do they use a multimedia approach to make healthy behaviors more enjoyable for users?Join us on May 4 at 1PM ET for our webinar: 'Leader Series: Modern Data Strategies in Healthcare.' This webinar will focus on exploring data governance and analytics strategies that have the potential to revolutionize healthcare in the modern era. With a data-driven approach, we can improve patient care outcomes, increase efficiency, and reduce costs in the healthcare industry. Register Here: https://thisweekhealth.com/modern-data-strategies/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Jonathan Baktari MD brings over 20 years of clinical, administrative, and entrepreneurial experience. He has been a triple board-certified physician with specialties in internal medicine, pulmonary, and critical care medicine.Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield, and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.Learn more: https://jonathanbaktarimd.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-jonathan-baktari-md-ceo-of-e7-health-and-us-drug-test-centers

Jonathan Baktari MD brings over 20 years of clinical, administrative, and entrepreneurial experience. He has been a triple board-certified physician with specialties in internal medicine, pulmonary, and critical care medicine.Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield, and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.Learn more: https://jonathanbaktarimd.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-jonathan-baktari-md-ceo-of-e7-health-and-us-drug-test-centers

We don't often hear from a physician executive. When we do, I always appreciate their unique perspective. Physician executives have on-hands experience as a practitioner as well as an administrator. With us today is Dr. Craig Samitt who is the new CEO of the National Physician Enterprise for Surround Care which is the formation of two prominent organizations in Navvis Health a population health management company and Esse Health large multi-specialty group practice in St. Louis, MO. Craig's unique background affords him a broad view of the healthcare ecosystem. Craig was previously the CEO pf BCBSMN, and currently serves as the managing director for a venture firm. Craig has also worked in Clinical and leadership roles at Anthem, Healthcare Partners, Oliver Wyman and more. I have followed his career and am excited to have him with us today to share his perspective on industry challenges and changes.

Interview with Brandon Munro, MD/CEO, and Gavin Chamberlain, COO of Bannerman Energy (ASX: BMN).Bannerman Energy is an Australian listed uranium development company. Their flagship Etango Project is one of the world's largest undeveloped uranium assets. It is located in the highly established uranium mining jurisdiction of Namibia and they have environmental permits in place for development. Etango has been strongly de-risked through extensive drilling, technical evaluation and operation of a process demonstration plant facility.

S2E10: Civil War Medicine with Jon Bloom, MD, CEO & Co-Founder of Podimetrics and host Dr. Nick. We are living longer and healthier lives in the current times. But we are facing some rising challenges to the general health of the population. This is especially true in the US where declining number of health population metrics includes life span. And is contrary to other developed nations seeing continued improvements. On this episode, the silent killers, diabetes. Your better pill to swallow is to enable the delivery of prevention and care out in the community and the home. Empower patients to be fully engaged in their own wellness. Catch disease before it presents as a serious clinical condition and enable your patients to stay healthier. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

“Don't let other people control your agenda or the dynamics of your diary. I don't have any qualms saying to people that I'm postponing meetings and focusing on five things that are going to move the dial.” In this Best of Series episode, we hear from former MD & CEO of The Pact Group, Mal Bundey, on making a difference and bringing your ‘A Game'.

In this episode, I sat down with Iman Abuzeid, MD, CEO and Co-Founder of Incredible Health. Founded in 2017, Incredible Health, the highest valued tech-enabled career marketplace in healthcare, transforms the hiring process for both nurses and health systems. In August 2022, Incredible Health raised an $80M Series B round led by Base10 Partners. The company partners with over 600 top health systems across the country, has over 10,000 nurses joining its platform every single week, and has reduced the average timeline for hiring a nurse from 82 days to less than 14. Iman and I discuss: 1) her background in medicine and how she became a startup founder in the healthcare ecosystem, 2) the current nurse staffing crisis that's on track to leave the US 1M nurses short by the end of 2023 and how we got here, 3) how Incredible Health is reducing nurse burnout, improving retention, and empowering hospitals to set up their nursing workforces for career advancement, and 4) Iman's evolution as a leader and how she has invested in herself and her team to keep up with the company's growth.

Tune into this episode with the Chief Executive Officer of North American Partners in Anesthesia (NAPA), John F. Di Capua, MD. In this conversation we talk about how the No Surprises Act and IDR process are impacting access to healthcare, and what we can do about the long and short-term staffing shortage. This episode is sponsored by North American Partners in Anesthesia.

It's inventors week on SleepTech Talk with Dr. William Noah! Dr Noah has invented a revolutionary device to make CPAP more comfortable for patients and increase adherence. The V-Com, which softens peak inspiratory flow, makes starting CPAP easier and faster. V-Com is an accessory added between the CPAP mask and the CPAP hose that is specifically engineered to reduce inspiratory pressure and flow to provide comfort with minimal to no reduction in expiratory pressure (EPAP). Since V-Com has minimal effect on EPAP, there is minimal effect on therapy. After weeks or months when the patient can easily tolerate the peak flow and inspiratory pressure of PAP therapy, the V-Com can be removed from the circuit. Join us as we learn more about this new tool that can help our patients tolerate PAP therapy and improve overall adherence! To learn more or to request a free sample of the V-Com - https://sleepres.com/v-com/ Intro music Pierce G. Mann Sound Diego R. Mann

Friends, Just about every major industry, with the exception of healthcare, has moved into the digital era. This is not my opinion alone. It is the collective perspective of the ...